What is NDC 70771-1826?

70771-1826 is the product NDC for Tavaborole, Tavaborole 43.5 mg/mL solution, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tavaborole?

6 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tavaborole NDC 70771-1826 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1826Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1826Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1826-0	7077118260070771182600	1 BOTTLE, WITH APPLICATOR in 1 CARTON (70771-1826-0) / 10 mL in 1 BOTTLE, WITH APPLICATORMarketed from Apr 24, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tavaborole
Generic name (nonproprietary): tavaborole
Active ingredients: Tavaborole — 43.5 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212294
Marketing start: Apr 24, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Boron Compounds (Chemical structure)Protein Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 70771-1826_b7ea9baf-cd2b-4430-a0cf-85945ce38a17SPL ID b7ea9baf-cd2b-4430-a0cf-85945ce38a17SPL set ID 15bc62dc-4f5e-4d43-a125-d1f00bee84a5RxCUI 1543177UNII K124A4EUQ3
Pharmacologic class: Oxaborole Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771182600 followed by a unit qualifier and the quantity

Package 70771-1826-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 6, 2024.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1826

What is NDC 70771-1826?: 70771-1826 is the product NDC for Tavaborole, Tavaborole 43.5 mg/mL solution, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tavaborole.
What is the active ingredient?: Tavaborole.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tavaborole?: 6 other product NDCs are listed under this name. See all Tavaborole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tavaborole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tavaborole	Tavaborole 43.5 mg/mL	SolutionTopical	Alembic Pharmaceuticals Limited	46708-467	46708-0467-0446708-0467-10
Tavaborole	Tavaborole 43.5 mg/mL	SolutionTopical	Viona Pharmaceuticals Inc	72578-102	72578-0102-04
Tavaborole	Tavaborole 43.5 mg/mL	SolutionTopical	Chartwell RX, LLC	62135-663	62135-0663-59
tavaborole	Tavaborole 43.5 mg/mL	SolutionTopical	Mayne Pharma Commercial LLC	51862-690	—
Tavaborole	Tavaborole 43.5 mg/mL	SolutionTopical	Alembic Pharmaceuticals Inc.	62332-467	62332-0467-0462332-0467-10
Tavaboroletavaborole topical solution, 5%	Tavaborole 43.5 mg/mL	SolutionTopical	Encube Ethicals, Inc.	21922-020	21922-0020-12

Other NDCs under ANDA 212294

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212294
Product	Strength	Form · route	Labeler	Product NDC
Tavaborole	Tavaborole 43.5 mg/mL	SolutionTopical	Viona Pharmaceuticals Inc	72578-102